Breast cancer patients may use fertility preservation or assisted reproductive technologies

Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused endocrine therapy to become pregnant, according to results from the POSITIVE trial presented at the San Antonio Breast Cancer Symposium, held December 5–9, 2023.